NCT05018897

Brief Summary

While suicide prevention depends on people disclosing suicidal thoughts and behaviors in order to get help, those who talk about their suicidality also face negative responses from the people who they tell. The investigators will conduct a randomized controlled trial of a peer-led strategic disclosure intervention for suicide attempt survivors (The To Share or Not to Share Program; called 2Share). This study evaluates the impact of the intervention on suicidal thoughts and behaviors, depression, stigma, disclosure behaviors, and psychosocial outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 1, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 24, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
Last Updated

August 10, 2022

Status Verified

August 1, 2022

Enrollment Period

1.4 years

First QC Date

June 1, 2021

Last Update Submit

August 9, 2022

Conditions

Keywords

peer interventionvirtual interventionsuicidedisclosure

Outcome Measures

Primary Outcomes (2)

  • Change from Baseline in suicidality on the 9-item Suicidal Ideation Attributes Scale (SIDAS) at Week 6 and Week 19

    The SIDAS is a validated, self-reported instrument assessing suicidality over the past month. Possible item scores range from 0 (no thoughts) to 10 (always) Change = (Week 6 Score - Baseline Score), (Week 19 - Baseline Score)

    Baseline, Week 6, Week 19

  • Change from Baseline in depression on the 10- item Center for Epidemiologic Studies Depression Scale (CESD-10) at Week 6 and Week 19

    he CESD-10 is a validated, self-reported instrument assessing depression over the past week. Possible item scores range from 1 (rarely to none of the time) to 4 (most or all of the time)

    Baseline, Week 6, Week 19

Secondary Outcomes (9)

  • Change from Baseline in internalized stigma on the 9- item Internalized Stigma of Suicide (ISSA) at Week 6 and Week 19

    Baseline, Week 6, Week 19

  • Change from Baseline in stigma-related stress on the 8- item Suicide Stigma Stress Scale (4S) at Week 6 and Week 19

    Baseline, Week 6, Week 19

  • Change from Baseline in self-esteem on the 10- item Rosenberg Self-Esteem (RSE) scale at Week 6 and Week 19

    Baseline, Week 6, Week 19

  • Change from Baseline in disclosure self-efficacy on the 2- item Disclosure Self-Efficacy (DSE) scale at Week 6 and Week 19

    Baseline, Week 6, Week 19

  • Change from Baseline in secrecy on the 14- item Self-Harm and Suicide Disclosure Scale (SHSDS) at Week 6 and Week 19

    Baseline, Week 6, Week 19

  • +4 more secondary outcomes

Study Arms (2)

To Share or Not to Share

EXPERIMENTAL

Manualized, peer-led, strategic disclosure program to guide participants in disclosing suicidality, held in group format, consisting of six sessions, each one hour in duration, once per week. Pre-survey, post-survey, and 3-month follow-up survey

Behavioral: To Share or Not to Share

Peer Support

ACTIVE COMPARATOR

Peer-led support group, held in group format, consisting of six sessions, each one hour in duration, once per week. Pre-survey, post-survey, and 3-month follow-up survey

Behavioral: Peer Support

Interventions

Strategic disclosure intervention to help participants evaluate the pros and cons of disclosing suicidality and provide guidance on best way to disclose to get needs met. Six one-hour virtual sessions conducted weekly.

To Share or Not to Share
Peer SupportBEHAVIORAL

Peer-led support group for mood disorders. Six one-hour virtual sessions conducted weekly.

Peer Support

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • self-reported diagnosis of mood disorder
  • At least one lifetime suicide attempt

You may not qualify if:

  • a self-reported suicide attempt within the last 3 months
  • do have concerns about disclosure/ not willing to participate in program
  • do not have email address
  • do not have technical capability to connect to virtual platform
  • cannot speak or read English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Illinois Institute of Technology

Chicago, Illinois, 60616, United States

Location

MeSH Terms

Conditions

Suicide, AttemptedMood DisordersSuicide

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehaviorMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Randomized controlled trial with two comparison groups
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 1, 2021

First Posted

August 24, 2021

Study Start

March 1, 2021

Primary Completion

August 1, 2022

Study Completion

August 1, 2022

Last Updated

August 10, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will share

Results will be available through the National Institute of Mental Health (NIMH) Data Archive and through the project website at the National Consortium on Stigma and Empowerment (NCSE). No identifying information will be connected to the data and we do not believe that there is a possibility of deductive disclosure of subjects with unusual characteristics. We will certify the quality of all data prior to submission to New Drugs and Clinical Trials (NDCT). Descriptive/raw data will be submitted semi-annually (prior to January 15 and July 15) and will be checked for quality within four months. All other data will be submitted at the time of publication, or prior to the end of the grant, whichever occurs first. The final de-identified dataset and codebook will be posted on NCSE website at the time of publication. We will share results, positive and negative, specific to the cohorts and outcome measures studied by using the Study functionality.

Time Frame
The final de-identified dataset and codebook will be shared at the time of publication.

Locations